HCAT (Health Catalyst) Piotroski F-Score: 4 (As of Jun. 24, 2026) — Near Median


HCAT Health Catalyst Inc HCAT
49 GF Score
Price $1.72
GF Value $5.07
Valuation Possible Value Trap
! 5 Warning Signs
View Full Analysis

What is Health Catalyst Piotroski F-Score?

Health Catalyst HCAT -1.71% 49 Piotroski F-Score is 4 as of Jun. 24, 2026, which is at its 10-year median of 4.00. GuruFocus rates HCAT with a GF Score™ of 49/100 and a GF Value™ of $5.07 (Possible Value Trap). The stock has 5 warning signs investors should review. Among 651 Healthcare Providers & Services companies, Health Catalyst ranks worse than 67.43% on this metric.

The zones of discrimination were as such:

Good or high score = 7, 8, 9
Bad or low score = 0, 1, 2, 3

Health Catalyst has an F-score of 4 indicating the company's financial situation is typical for a stable company.

The historical rank and industry rank for Health Catalyst's Piotroski F-Score or its related term are showing as below:

HCAT' s Piotroski F-Score Range Over the Past 10 Years
Min: 2   Med: 4   Max: 6
Current: 4

During the past 9 years, the highest Piotroski F-Score of Health Catalyst was 6. The lowest was 2. And the median was 4.

Health Catalyst  (NAS:HCAT) Piotroski F-Score Explanation

The developer of the system is Joseph D. Piotroski is relatively unknown accounting professor who shuns publicity and rarely gives interviews.

He graduated from the University of Illinois with a B.S. in accounting in 1989, received an M.B.A. from Indiana University in 1994. Five years later, in 1999, after earning a Ph.D. in accounting from the University of Michigan, he became an associate professor of accounting at the University of Chicago.

In 2000, he wrote a research paper called "Value Investing: The Use of Historical Financial Statement Information to Separate Winners from Losers" (pdf).

He wanted to see if he can develop a system (using a simple nine-point scoring system) that can increase the returns of a strategy of investing in low price to book (referred to in the paper as high book to market) value companies.

What he found was something that exceeded his most optimistic expectations.

Buying only those companies that scored highest (8 or 9) on his nine-point scale, or F-Score as he called it, over the 20 year period from 1976 to 1996 led to an average out-performance over the market of 13.4%.

Even more impressive were the results of a strategy of investing in the highest F-Score companies (8 or 9) and shorting companies with the lowest F-Score (0 or 1).

Over the same period from 1976 to 1996 (20 years) this strategy led to an average yearly return of 23%, substantially outperforming the average S&P 500 index return of 15.83% over the same period.


Health Catalyst Piotroski F-Score Related Terms


Health Catalyst Piotroski F-Score Historical Data

* Premium members only.

The historical data trend for Health Catalyst's Piotroski F-Score can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Health Catalyst Piotroski F-Score Chart

Health Catalyst Annual Data
Trend Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Piotroski F-Score
Get a 7-Day Free Trial Premium Member Only 5.00 2.00 3.00 6.00 4.00

Health Catalyst Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Piotroski F-Score Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 6.00 4.00 3.00 4.00 4.00

HCAT vs CCLD, DH, OPRX: Piotroski F-Score Comparison

For the Health Information Services subindustry, Health Catalyst's Piotroski F-Score, along with its competitors' market caps and Piotroski F-Score data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Health Catalyst Piotroski F-Score vs Healthcare Providers & Services Industry

For the Healthcare Providers & Services industry and Healthcare sector, Health Catalyst's Piotroski F-Score distribution charts can be found below:

* The bar in red indicates where Health Catalyst's Piotroski F-Score falls into.


HCAT
49GF Score
Health Catalyst Inc HCAT
Piotroski F-Score is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

How is the Piotroski F-Score calculated?

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

This Year (Mar26) TTM:Last Year (Mar25) TTM:
Net Income was -40.978 + -22.229 + -91.025 + -111.026 = $-265.3 Mil.
Cash Flow from Operations was -8.997 + -0.464 + 9.912 + 18.511 = $19.0 Mil.
Revenue was 80.721 + 76.323 + 74.679 + 70.756 = $302.5 Mil.
Gross Profit was 38.241 + 37.816 + 39.383 + 35.463 = $150.9 Mil.
Average Total Assets from the begining of this year (Mar25)
to the end of this year (Mar26) was
(891.542 + 616.18 + 587.128 + 502.643 + 412.202) / 5 = $601.939 Mil.
Total Assets at the begining of this year (Mar25) was $891.5 Mil.
Long-Term Debt & Capital Lease Obligation was $165.2 Mil.
Total Current Assets was $182.3 Mil.
Total Current Liabilities was $107.6 Mil.
Net Income was -13.516 + -14.726 + -20.673 + -23.742 = $-72.7 Mil.

Revenue was 75.902 + 76.353 + 79.606 + 79.413 = $311.3 Mil.
Gross Profit was 35.842 + 34.04 + 34.691 + 36.235 = $140.8 Mil.
Average Total Assets from the begining of last year (Mar24)
to the end of last year (Mar25) was
(695.112 + 691.72 + 813.05 + 858.929 + 891.542) / 5 = $790.0706 Mil.
Total Assets at the begining of last year (Mar24) was $695.1 Mil.
Long-Term Debt & Capital Lease Obligation was $167.0 Mil.
Total Current Assets was $422.7 Mil.
Total Current Liabilities was $339.6 Mil.

*Note: If the latest quarterly/semi-annual/annual total assets data is 0, then we will use previous quarterly/semi-annual/annual data for all the items in the balance sheet.

Profitability

Question 1. Return on Assets (ROA)

Net income before extraordinary items for the year divided by Total Assets at the beginning of the year.

Score 1 if positive, 0 if negative.

Health Catalyst's current Net Income (TTM) was -265.3. ==> Negative ==> Score 0.

Question 2. Cash Flow Return on Assets (CFROA)

Net cash flow from operating activities (operating cash flow) divided by Total Assets at the beginning of the year.

Score 1 if positive, 0 if negative.

Health Catalyst's current Cash Flow from Operations (TTM) was 19.0. ==> Positive ==> Score 1.

Question 3. Change in Return on Assets

Compare this year's return on assets (1) to last year's return on assets.

Score 1 if it's higher, 0 if it's lower.

ROA (This Year)=Net Income/Total Assets (Mar25)
=-265.258/891.542
=-0.29752721

ROA (Last Year)=Net Income/Total Assets (Mar24)
=-72.657/695.112
=-0.1045256

Health Catalyst's return on assets of this year was -0.29752721. Health Catalyst's return on assets of last year was -0.1045256. ==> Last year is higher ==> Score 0.

Question 4. Quality of Earnings (Accrual)

Compare Cash flow return on assets (2) to return on assets (1)

Score 1 if CFROA > ROA, 0 if CFROA <= ROA.

Health Catalyst's current Net Income (TTM) was -265.3. Health Catalyst's current Cash Flow from Operations (TTM) was 19.0. ==> 19.0 > -265.3 ==> CFROA > ROA ==> Score 1.

Funding

Question 5. Change in Gearing or Leverage

Compare this year's gearing (long-term debt divided by average total assets) to last year's gearing.

Score 0 if this year's gearing is higher, 1 otherwise.

Gearing (This Year: Mar26)=Long-Term Debt & Capital Lease Obligation/Average Total Assets from Mar25 to Mar26
=165.22/601.939
=0.27447964

Gearing (Last Year: Mar25)=Long-Term Debt & Capital Lease Obligation/Average Total Assets from Mar24 to Mar25
=167.042/790.0706
=0.21142668

Health Catalyst's gearing of this year was 0.27447964. Health Catalyst's gearing of last year was 0.21142668. ==> Last year is lower than this year ==> Score 0.

Question 6. Change in Working Capital (Liquidity)

Compare this year's current ratio (current assets divided by current liabilities) to last year's current ratio.

Score 1 if this year's current ratio is higher, 0 if it's lower

Current Ratio (This Year: Mar26)=Total Current Assets/Total Current Liabilities
=182.312/107.613
=1.69414476

Current Ratio (Last Year: Mar25)=Total Current Assets/Total Current Liabilities
=422.716/339.561
=1.24488973

Health Catalyst's current ratio of this year was 1.69414476. Health Catalyst's current ratio of last year was 1.24488973. ==> This year's current ratio is higher. ==> Score 1.

Question 7. Change in Shares in Issue

Compare the number of shares in issue this year, to the number in issue last year.

Score 0 if there is larger number of shares in issue this year, 1 otherwise.

Health Catalyst's number of shares in issue this year was 72.593. Health Catalyst's number of shares in issue last year was 68.552. ==> There is larger number of shares in issue this year. ==> Score 0.

Efficiency

Question 8. Change in Gross Margin

Compare this year's gross margin (Gross Profit divided by sales) to last year's.

Score 1 if this year's gross margin is higher, 0 if it's lower.

Gross Margin (This Year: TTM)=Gross Profit/Revenue
=150.903/302.479
=0.49888753

Gross Margin (Last Year: TTM)=Gross Profit/Revenue
=140.808/311.274
=0.4523603

Health Catalyst's gross margin of this year was 0.49888753. Health Catalyst's gross margin of last year was 0.4523603. ==> This year's gross margin is higher. ==> Score 1.

Question 9. Change in asset turnover

Compare this year's asset turnover (total sales for the year divided by total assets at the beginning of the year) to last year's asset turnover ratio.

Score 1 if this year's asset turnover ratio is higher, 0 if it's lower

Asset Turnover (This Year)=Revenue/Total Assets at the Beginning of This Year (Mar25)
=302.479/891.542
=0.33927622

Asset Turnover (Last Year)=Revenue/Total Assets at the Beginning of Last Year (Mar24)
=311.274/695.112
=0.44780409

Health Catalyst's asset turnover of this year was 0.33927622. Health Catalyst's asset turnover of last year was 0.44780409. ==> Last year's asset turnover is higher ==> Score 0.

Evaluation

Piotroski F-Score= Que. 1+ Que. 2+ Que. 3+Que. 4+Que. 5+Que. 6+Que. 7+Que. 8+Que. 9
=0+1+0+1+0+1+0+1+0
=4

Good or high score = 7, 8, 9
Bad or low score = 0, 1, 2, 3

Health Catalyst has an F-score of 4 indicating the company's financial situation is typical for a stable company.

Frequently Asked Questions Learn more about Piotroski F-Score →
What does a Piotroski F-Score of 4 mean?
Health Catalyst (HCAT) has a Piotroski F-Score of 4 as of Jun. 24, 2026. The Piotroski F-score grades a company's business operating strength from 0-9. View historical data on Health Catalyst and its competitors. This is near median its historical median of 4.00. Over the past decade, Health Catalyst's Piotroski F-Score has ranged from 2.00 to 6.00. According to the industry distribution chart, Health Catalyst ranks #439 out of 651 companies in the Healthcare Providers & Services industry, placing it in the top 67.4%.
Is Health Catalyst's Piotroski F-Score too high?
Health Catalyst's current Piotroski F-Score of 4 is near median its 10-year median of 4.00. Over the past 10 years, this metric has ranged from a low of 2.00 to a high of 6.00. The Healthcare Providers & Services industry median Piotroski F-Score is 5.00. Health Catalyst's value of 4 is 20% below this industry median. Based on the distribution chart, Health Catalyst ranks #439 out of 651 companies in the Healthcare Providers & Services industry, which is below the industry midpoint. Overall, Health Catalyst has a GF Score™ of 49/100 and is considered Possible Value Trap, reflecting its overall financial health beyond just this single metric.
How does Health Catalyst's Piotroski F-Score compare to CCLD and DH?
According to the Healthcare Providers & Services industry distribution chart, Health Catalyst ranks #439 out of 651 companies for Piotroski F-Score. This places Health Catalyst in the lower half of its industry. The industry median Piotroski F-Score is 5.00. Health Catalyst's value of 4 is 20% below this benchmark. Historically, Health Catalyst's own Piotroski F-Score has ranged from 2.00 to 6.00 over the past decade. While the company's 10-year median is 4.00 vs. the industry median of 5.00, Health Catalyst has consistently been below the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Piotroski F-Score for a Healthcare Providers & Services company?
The median Piotroski F-Score among Healthcare Providers & Services companies is 5.00, based on 651 companies in the industry. Companies in the top quartile (top 25%) have a Piotroski F-Score significantly above this median, while those in the bottom quartile fall well below. However, Piotroski F-Score should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Health Catalyst's current Piotroski F-Score of 4 is 20% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Piotroski F-Score mean?
A high Piotroski F-Score can signal that a stock is expensive relative to its fundamentals. The Piotroski F-score grades a company's business operating strength from 0-9. View historical data on Health Catalyst and its competitors. For the Healthcare Providers & Services industry, the median Piotroski F-Score is 5.00 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Health Catalyst's current Piotroski F-Score is 4, which is near median its own 10-year median of 4.00. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Health Catalyst stock overvalued right now?
Based on GuruFocus' analysis, Health Catalyst (HCAT) is currently considered Possible Value Trap. The stock's GF Value™ is $5.07, compared to a current price of $1.72 — trading 66.1% below its estimated fair value. The current Piotroski F-Score is 4, which is near median its 10-year median of 4.00 and 20% below the Healthcare Providers & Services industry median of 5.00. Health Catalyst's overall GF Score™ is 49/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Piotroski F-Score calculated?
Piotroski F-Score is calculated from a company's financial statements. For Health Catalyst (HCAT), the current Piotroski F-Score is 4 as of Jun. 24, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Health Catalyst (HCAT) Overvalued in 2026?

Based on GuruFocus' analysis, Health Catalyst stock appears to be undervalued. The current stock price of $1.72 is trading 66.1% below its estimated GF Value™ of $5.07. GuruFocus considers Health Catalyst to be Possible Value Trap.

Key valuation signals for HCAT:

  • Piotroski F-Score: 4 (near median its 10-year median of 4.00)
  • GF Value™: $5.07 vs. price of $1.72 (66.1% below fair value)
  • GF Score™: 49/100 with 5 warning signs
  • Industry Position: 20% below the Healthcare Providers & Services median (#439 of 651)

No single metric tells the full story. See the HCAT stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Health Catalyst Business Description

Other Exchanges 2YP:Germany
Address 10897 South River Front Parkway, Suite 300, South Jordan, UT, USA, 84095
Health Catalyst Inc provides data and analytics technology and services to healthcare organizations. It has two operating segments. The Technology segment, the key revenue driver, includes data platform, analytics applications and support services and generates revenues mainly from contracts that are cloud-based subscription arrangements, time-based license arrangements, and maintenance and support fees; the Professional Services segment is generally the combination of analytics, implementation, strategic advisory, outsourcing, and improvement services to deliver expertise to its customers to more fully configure and utilize the benefits of the technology offerings.
49GF Score

Get the complete analysis for HCAT

Piotroski F-Score is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$1.72
Price
$5.07
GF Value